Merck Bolsters Oncology Portfolio With Another AcquisitionBy Offit Kurman | November 5, 2020 | 0 Merck has been active in dealmaking recently completing its acquisitions of ArQule and Themis.Leave a Comment Cancel ReplyCommentName (required) Email (will not be published) (required) Website